Pacific Biosciences of California Inc
NASDAQ:PACB
Income Statement
Earnings Waterfall
Pacific Biosciences of California Inc
Revenue
|
200.5m
USD
|
Cost of Revenue
|
-144.3m
USD
|
Gross Profit
|
56.2m
USD
|
Operating Expenses
|
-378.2m
USD
|
Operating Income
|
-322m
USD
|
Other Expenses
|
15.3m
USD
|
Net Income
|
-306.7m
USD
|
Income Statement
Pacific Biosciences of California Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
28
N/A
|
34
+22%
|
40
+16%
|
53
+33%
|
61
+15%
|
67
+10%
|
80
+20%
|
73
-8%
|
93
+26%
|
94
+2%
|
90
-4%
|
101
+12%
|
91
-10%
|
97
+6%
|
96
-1%
|
94
-2%
|
94
-1%
|
88
-6%
|
89
+2%
|
84
-6%
|
79
-6%
|
76
-4%
|
79
+4%
|
83
+5%
|
91
+10%
|
90
-1%
|
83
-8%
|
80
-3%
|
79
-1%
|
92
+17%
|
106
+15%
|
122
+15%
|
131
+7%
|
135
+3%
|
140
+4%
|
137
-2%
|
128
-6%
|
134
+4%
|
146
+9%
|
170
+16%
|
201
+18%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(22)
|
(26)
|
(29)
|
(31)
|
(37)
|
(40)
|
(42)
|
(42)
|
(39)
|
(37)
|
(37)
|
(42)
|
(47)
|
(53)
|
(55)
|
(58)
|
(59)
|
(55)
|
(56)
|
(55)
|
(54)
|
(53)
|
(55)
|
(55)
|
(56)
|
(53)
|
(49)
|
(46)
|
(46)
|
(54)
|
(61)
|
(68)
|
(72)
|
(75)
|
(77)
|
(76)
|
(76)
|
(86)
|
(98)
|
(117)
|
(144)
|
|
Gross Profit |
6
N/A
|
8
+27%
|
10
+25%
|
22
+116%
|
23
+6%
|
27
+14%
|
38
+43%
|
31
-17%
|
54
+70%
|
57
+7%
|
53
-7%
|
59
+11%
|
44
-25%
|
44
-1%
|
41
-6%
|
37
-11%
|
35
-5%
|
33
-5%
|
34
+3%
|
29
-15%
|
25
-13%
|
23
-9%
|
24
+3%
|
27
+16%
|
35
+26%
|
37
+7%
|
34
-8%
|
34
+0%
|
33
-4%
|
38
+17%
|
45
+19%
|
53
+18%
|
59
+10%
|
60
+2%
|
62
+4%
|
61
-3%
|
53
-13%
|
48
-8%
|
48
-1%
|
52
+9%
|
56
+8%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(84)
|
(83)
|
(84)
|
(84)
|
(86)
|
(91)
|
(95)
|
(100)
|
(106)
|
(85)
|
(88)
|
(114)
|
(115)
|
(120)
|
(123)
|
(124)
|
(125)
|
(123)
|
(122)
|
(120)
|
(126)
|
(130)
|
(133)
|
(141)
|
(135)
|
(140)
|
(136)
|
(132)
|
(137)
|
(143)
|
(165)
|
(192)
|
(238)
|
(283)
|
(316)
|
(345)
|
(356)
|
(369)
|
(370)
|
(373)
|
(378)
|
|
Selling, General & Administrative |
(39)
|
(38)
|
(38)
|
(37)
|
(38)
|
(40)
|
(41)
|
(42)
|
(45)
|
(46)
|
(47)
|
(48)
|
(48)
|
(51)
|
(56)
|
(58)
|
(59)
|
(59)
|
(58)
|
(58)
|
(64)
|
(68)
|
(72)
|
(79)
|
(76)
|
(81)
|
(77)
|
(71)
|
(73)
|
(74)
|
(88)
|
(105)
|
(124)
|
(138)
|
(148)
|
(153)
|
(161)
|
(161)
|
(162)
|
(169)
|
(170)
|
|
Research & Development |
(45)
|
(45)
|
(46)
|
(47)
|
(48)
|
(51)
|
(54)
|
(58)
|
(60)
|
(62)
|
(65)
|
(66)
|
(68)
|
(68)
|
(68)
|
(66)
|
(65)
|
(65)
|
(63)
|
(62)
|
(63)
|
(62)
|
(61)
|
(62)
|
(60)
|
(59)
|
(59)
|
(61)
|
(64)
|
(69)
|
(77)
|
(88)
|
(113)
|
(145)
|
(173)
|
(193)
|
(193)
|
(189)
|
(185)
|
(185)
|
(187)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(6)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
5
|
1
|
(2)
|
(19)
|
(23)
|
(19)
|
(15)
|
|
Operating Income |
(78)
N/A
|
(75)
+3%
|
(73)
+2%
|
(62)
+16%
|
(63)
-2%
|
(64)
-2%
|
(57)
+11%
|
(69)
-21%
|
(52)
+25%
|
(28)
+46%
|
(35)
-24%
|
(54)
-55%
|
(71)
-31%
|
(76)
-7%
|
(82)
-8%
|
(87)
-6%
|
(90)
-3%
|
(90)
-1%
|
(88)
+3%
|
(91)
-4%
|
(101)
-11%
|
(107)
-6%
|
(110)
-2%
|
(113)
-3%
|
(101)
+11%
|
(103)
-3%
|
(102)
+1%
|
(98)
+4%
|
(104)
-6%
|
(105)
-1%
|
(119)
-13%
|
(139)
-16%
|
(179)
-29%
|
(223)
-24%
|
(254)
-14%
|
(284)
-12%
|
(304)
-7%
|
(321)
-6%
|
(322)
0%
|
(321)
+0%
|
(322)
0%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(2)
|
(5)
|
(9)
|
(13)
|
(14)
|
(15)
|
(15)
|
(15)
|
(15)
|
(14)
|
(14)
|
(14)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
52
|
52
|
52
|
132
|
46
|
46
|
15
|
(83)
|
(31)
|
(31)
|
(0)
|
(4)
|
0
|
(6)
|
(15)
|
(15)
|
|
Total Other Income |
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
(0)
|
(0)
|
1
|
8
|
15
|
23
|
31
|
33
|
|
Pre-Tax Income |
(79)
N/A
|
(77)
+3%
|
(76)
+2%
|
(64)
+15%
|
(66)
-3%
|
(67)
-2%
|
(60)
+11%
|
(49)
+18%
|
(32)
+36%
|
(31)
+3%
|
(37)
-21%
|
(57)
-52%
|
(74)
-31%
|
(79)
-6%
|
(86)
-9%
|
(90)
-5%
|
(92)
-2%
|
(93)
0%
|
(90)
+3%
|
(93)
-3%
|
(103)
-11%
|
(109)
-6%
|
(111)
-2%
|
(115)
-4%
|
(84)
+27%
|
(53)
+38%
|
(51)
+3%
|
(46)
+11%
|
29
N/A
|
(59)
N/A
|
(77)
-30%
|
(132)
-71%
|
(275)
-109%
|
(269)
+2%
|
(299)
-11%
|
(298)
+0%
|
(314)
-5%
|
(321)
-2%
|
(319)
+0%
|
(320)
0%
|
(318)
+1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
95
|
94
|
0
|
0
|
(1)
|
0
|
0
|
0
|
11
|
11
|
|
Income from Continuing Operations |
(79)
|
(77)
|
(76)
|
(64)
|
(66)
|
(67)
|
(60)
|
(49)
|
(32)
|
(31)
|
(37)
|
(57)
|
(74)
|
(79)
|
(86)
|
(90)
|
(92)
|
(93)
|
(90)
|
(93)
|
(103)
|
(109)
|
(111)
|
(115)
|
(84)
|
(53)
|
(51)
|
(46)
|
29
|
(59)
|
(77)
|
(37)
|
(181)
|
(175)
|
(206)
|
(299)
|
(314)
|
(321)
|
(319)
|
(309)
|
(307)
|
|
Net Income (Common) |
(79)
N/A
|
(77)
+3%
|
(76)
+2%
|
(64)
+15%
|
(66)
-3%
|
(67)
-2%
|
(60)
+11%
|
(49)
+18%
|
(32)
+36%
|
(31)
+3%
|
(37)
-21%
|
(57)
-52%
|
(74)
-31%
|
(79)
-6%
|
(86)
-9%
|
(90)
-5%
|
(92)
-2%
|
(93)
0%
|
(90)
+3%
|
(93)
-3%
|
(103)
-11%
|
(109)
-6%
|
(111)
-2%
|
(115)
-4%
|
(84)
+27%
|
(53)
+38%
|
(51)
+3%
|
(46)
+11%
|
29
N/A
|
(59)
N/A
|
(77)
-30%
|
(37)
+52%
|
(181)
-390%
|
(175)
+3%
|
(206)
-17%
|
(299)
-45%
|
(314)
-5%
|
(321)
-2%
|
(319)
+0%
|
(309)
+3%
|
(307)
+1%
|
|
EPS (Diluted) |
-1.19
N/A
|
-1.13
+5%
|
-1.07
+5%
|
-0.91
+15%
|
-0.94
-3%
|
-0.9
+4%
|
-0.82
+9%
|
-0.61
+26%
|
-0.42
+31%
|
-0.36
+14%
|
-0.44
-22%
|
-0.61
-39%
|
-0.83
-36%
|
-0.84
-1%
|
-0.88
-5%
|
-0.78
+11%
|
-0.87
-12%
|
-0.74
+15%
|
-0.67
+9%
|
-0.68
-1%
|
-0.76
-12%
|
-0.71
+7%
|
-0.72
-1%
|
-0.76
-6%
|
-0.55
+28%
|
-0.34
+38%
|
-0.33
+3%
|
-0.28
+15%
|
0.17
N/A
|
-0.3
N/A
|
-0.38
-27%
|
-0.17
+55%
|
-0.89
-424%
|
-0.78
+12%
|
-0.92
-18%
|
-1.34
-46%
|
-1.4
-4%
|
-1.32
+6%
|
-1.27
+4%
|
-1.21
+5%
|
-1.21
N/A
|